期刊文献+

下肢骨巨细胞瘤CT和MRI影像学表现与术后复发的相关性分析 被引量:5

An Analysis On The Correlation Between Recurrence of GCTB in Lower Limbs and Its CT and MR Imaging
原文传递
导出
摘要 目的回顾性分析下肢骨巨细胞瘤CT和MRI表现与术后复发的相关性,为预测术后复发及制定临床诊疗方案提供影像学依据。方法回顾1999年至2014年59例下肢骨单发骨巨细胞瘤患者术后复发情况,分析其术前CT与MRI影像资料。观察CT骨棘与骨皮质破坏表现及MRI囊性变、周围组织水肿、瘤内液化坏死出血、软组织侵袭及肿瘤边缘低信号是否完整等表现,并分析以上表现与复发的相关性。结果 MRI所示的瘤内出血液化坏死表现在复发与无复发两组中具有统计学差异(P<0.05)。其余影像学表现在复发与无复发两组中均无统计学差异。结论骨巨细胞瘤MRI所示的瘤内出血液化坏死表现与肿瘤术后复发相关,对临床治疗方案的制定具有指导意义。 Objective To investigate the correlation between the CT and MRI imaging of GCTB in the lower limbs and recurrence after surgery retrospectively,and to guide clinical treatment as well as predicting prognosis.Methods 59 cases diagnosed with GCTB in the lower limbs from 1999 to 2014 are analyzed retrospectively.The pre-operative CT and MRI imaging of 59 cases were collected.CT images were analyzed for presentation of bone crest and cortical breaking.MRI images were analyzed for presentation of cystic change,liquefaction/necrosis/hemorrhage,edema of the surrounding tissue,soft tissue extension and the integrity of the low signal margin.All data and information mentioned above are collected and analyzed to study the association with postoperative recurrence.Results The manifestation of hemorrhage/liquefaction/necrosis has significant difference between recurrence and non-recurrence(P〈0.05).Conversely,other presentations had no significant difference.Conclusion The manifestation of hemorrhage/liquefaction/necrosis observed on MRI images is associated with postoperative recurrence,which can offer guidance to clinical treatment.
出处 《临床放射学杂志》 CSCD 北大核心 2017年第4期546-550,共5页 Journal of Clinical Radiology
基金 上海市科学技术委员会基金资助项目(编号:134119a2400)
关键词 骨巨细胞瘤 体层摄影术 X线计算机 磁共振成像 术后复发 Giant cell tumor of bone Tomography X-ray computed Magnetic resonance imaging Recurrence
  • 相关文献

参考文献5

二级参考文献53

  • 1许良中,杨文涛.免疫组织化学反应结果的判断标准[J].中国癌症杂志,1996,6(4):229-231. 被引量:1365
  • 2郭茂凤,胡加令,丁乙.椎骨巨细胞瘤X线及CT表现特点[J].苏州医学院学报,1996,16(2):375-376. 被引量:3
  • 3李景学 孙鼎元.骨关节X线诊断学[M].北京:人民卫生出版社,1996.285-287.
  • 4Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumors of soft tissue and bone. 3rd ed[M]. Lyon: IARC Press, 2002:310-312.
  • 5Jaffe HL,Lichtanstoin I., Portis PB, et al. Giant cell tumor of bone: Its pathological appearance, grading, supposed varianls and treatment[J]. Arch Pathol, 1940, 30:993-997.
  • 6Htkin GJ, Haynes DR, Graves SE, et al. Expression of osteoclast differention singals by stromal elments of giant cell tumors[J].Journal of Bone and Mineral Research, 2000,15 (4) : 640-649.
  • 7Begun R, Nur-E-Kamal MS, Zaman MA, et al. The role of Rho GTPases in the regulation of the rearrangement of actin cytoskeleton and cell movement[J]. Exp Mol Med, 2004,36 (4) : 358-366.
  • 8Lin EY, Pollard JW. Macrophage: modulators of breast cancer progression[J]. Novartis Found Symp,2004,256:158-168.
  • 9Eubank TD,Galloway M, Montague CM,et al. M-CSF Induces vascular Endothelial growth factor production and angiogenic activity from human monocytes[J]. J Immunol,2003,17(5) :2 637-2 643.
  • 10Werner M. Giant cell tumour of bone: morphological, biological and Histogenetical aspects[J]. Int Orthop, 2006,30(6) :484-489.

共引文献57

同被引文献41

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部